Inflammation and Anti-Inflammatory Targets after Aneurysmal Subarachnoid Hemorrhage

Int J Mol Sci. 2021 Jul 8;22(14):7355. doi: 10.3390/ijms22147355.

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH), with a crude worldwide incidence of around 7 [...].

Keywords: cytokines; inflammation; post-SAH complications; subarachnoid hemorrhage.

Publication types

  • Editorial

MeSH terms

  • Adoptive Transfer
  • Aneurysm, Ruptured / complications*
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Cytokines / antagonists & inhibitors
  • Extracellular Vesicles
  • Humans
  • Immune Checkpoint Inhibitors / pharmacology
  • Immune Checkpoint Inhibitors / therapeutic use
  • Inflammation
  • Inflammation Mediators / antagonists & inhibitors
  • Intracranial Aneurysm / complications*
  • Intracranial Aneurysm / epidemiology
  • Molecular Targeted Therapy
  • Stem Cell Transplantation
  • Subarachnoid Hemorrhage / epidemiology
  • Subarachnoid Hemorrhage / etiology
  • Subarachnoid Hemorrhage / pathology
  • Subarachnoid Hemorrhage / therapy*
  • Vagus Nerve Stimulation
  • Vasospasm, Intracranial / complications
  • alpha7 Nicotinic Acetylcholine Receptor / drug effects

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Immune Checkpoint Inhibitors
  • Inflammation Mediators
  • alpha7 Nicotinic Acetylcholine Receptor